Hallman Director, School of Pharmacy
Director, Health Sciences Campus
Jake is a former professor and associate dean at the Leslie Dan Faculty of Pharmacy, University of Toronto. He earned his B.Sc. (Pharm) degree from the University of Manitoba, and went on to complete a M.Sc. at Manitoba and a Ph.D. at the University of California, San Francisco. Jake’s area of specialization is pharmacokinetics. His research interests include new approaches in cancer treatment and new molecules to treat patients with iron overload. He has broadened his experience and shared his expertise through work with the Drug Quality and Therapeutics Committee of the Ontario Ministry of Health, Health Canada’s Scientific Advisory Committee on Bioavailability and Bioequivalence, and the Canadian Council for Accreditation of Pharmacy Programs. As Director, Jake has overall strategic responsibility for establishing UW’s new School of Pharmacy and implementing a full educational program.
Dr. Michael Beazely Assistant Professor - Pharmaceutical Science
519 888 4567 x 21310
Dr. Beazely comes to UW after completing a CIHR post-doctoral fellowship at in the Department of Physiology at the University of Toronto. His work with one of the premier stroke researchers, and newly appointed Scientific Director of the Robarts Research Institute, John MacDonald, focused on the mechanisms of neuronal damage and death. Dr. Beazely completed his pharmacy degree at the University of Saskatchewan and his doctorate at Purdue University. The Beazely lab will be focused on intracellular signaling pathways in neurons. Specifically, how are excitatory neurotransmitter receptors regulated by intracellular signaling pathways initiated by growth factor receptors and other neurotransmitter receptors? In addition, there will be a focus on the role of cytoskeletal dynamics in the trafficking of receptors in neurons. These findings may lead to novel drug targets in neurodegenerative diseases (Alzheimer’s, Parkinson’s disease) and mental health conditions including schizophrenia and depression. Dr. Beazely is also involved in coordinating the pharmacology portion of the curriculum.
Dr. Andrea Edginton Assistant Professor - Pharmaceutical Science
519 888 4567 x21315
Dr. Edginton comes to UW from the Systems Biology group at Bayer Technology Services in Leverkusen, Germany. During her doctoral studies at the University of Guelph in environmental toxicology, Dr. Edginton became interested in the study of toxicokinetics.
During her tenure at Bayer, Dr. Edginton focused on the development and application of physiologically-based pharmacokinetic (PBPK) models and simulation techniques for the guidance of pharmaceutical dosing. More specifically, her research examines how the physiology of sub-populations, particularly children, affects the pharmacokinetics of drugs and how this information can be integrated into PBPK models for the optimization of drug therapy. Dr. Edginton is joining the School of Pharmacy to spearhead the pharmacokinetic educational requirements for both the undergraduate and graduate programs.
Canada Research Chair in Bionanotechnology and Nanomedicine
Associate Director, Research and Graduate Studies
Professor of Pharmaceutical Sciences
519-888-4567 x 21306
Dr. Foldvari comes to us from the University of Saskatchewan, where she was Professor of Pharmaceutical Sciences and Associate Dean of Research and Graduate Affairs at the College of Pharmacy and Nutrition.
As the Canada Research Chair in Bionanotechnology and Nanomedicine, Dr. Foldvari is one of a select group of Canadian scientists who has internationally recognized skills in bionanotechnology, a field targeted for development at the School of Pharmacy. She is also the Associate Director, Research and Graduate Studies, being responsible for establishing, developing and directing the School’s graduate-level research programs.
Her research focuses on the development of intelligent delivery systems and biomolecular devices with the goal of developing new, non-invasive technologies to deliver and target therapeutic agents into the body and to diseased tissues, as well as investigating the fundamental properties of these delivery technologies and the cells they target.
She has a DPharmSci in Pharmaceutical Sciences from Semmelweis Medical University in Budapest, Hungary and a PhD in Pharmaceutical Sciences from Dalhousie University.
Please visit Dr. Foldvari's Research Group pages....
Dr. Jamie JosephAssistant Professor - Pharmaceutical Science
519 888 4567 x21309
Dr. Joseph comes to UW after completing a CIHR post-doctoral fellowship at Duke University in Dr. Newgard’s laboratory. Dr. Newgard is the director of a world class diabetes and metabolism research center at Duke University in North Carolina. His work led to the discovery of a novel pathway involved in the regulation of insulin release from pancreatic ß-cells called pyruvate-cycling. Prior to this Dr. Joseph did his PhD at the University of Toronto in Dr. Wheeler’s laboratory looking at the role of the inner mitochondrial membrane protein uncoupling protein-2 in pancreatic ß-cell ATP production and insulin secretion. Dr. Joseph did his Master’s at the University of Toronto in Dr. Brubaker’s laboratory developing novel oral delivery systems for therapeutic peptides. Dr. Joseph’s laboratory at UW will focus on looking at the role of glucose in regulating insulin release from pancreatic ß-cells. For more details on his research program go to his website at www.betacellmetabolism.org.
Dr. Praveen NekkarAssistant Professor - Pharmaceutical Science
519 888 4567 x21317
Email
Research Website
Dr. Nekkar is a Medicinal Chemist by training. He joined UW after a post-doctoral stint at the Scripps Research Institute in Prof. Kelly’s laboratory. During this period he worked on developing methods to synthesize and incorporate backbone modified peptides into natural peptide/protein sequence. Prior to this, Dr. Nekkar graduated with a PhD in Pharmaceutical Sciences from University of Alberta in Prof. Knaus’s laboratory and went on to finish a post-doctoral training at the same Institution. During this period, he worked extensively on discovering novel anti-inflammatory and analgesic agents such as cyclooxygenase-2 (COX-2) inhibitors and dual inhibitors of COX/lipoxygenases (LOX). In addition, he worked as a Research Scientist at NAEJA Pharmaceuticals, Edmonton. Dr. Nekkar completed an undergraduate and a Master’s degree in Pharmacy from Manipal College of Pharmaceutical Sciences (MCOPS), India. The Nekkar laboratory will be working in the area of Drug Discovery with emphasis on rational design, synthesis and biological evaluation of novel organic molecules and peptides/peptidomimics as therapeutic agents.
Dr. Roderick SlavcevAssistant Professor - Pharmaceutical Science
519 888 4567 x21301
Research Website - Mediphage Bioceuticals
Roderick comes to the UW from the pharmaceutical industry. Prior to his work as a medical liaison for Janssen-Ortho Inc., he completed his post-doctoral fellowship at the Department of Medical Genetics and Microbiology at the University of Toronto in the area of bacteriophage P1 plasmid partition and chromosomal segregation. Roderick's interests are in genetics, molecular biology, virology and technology transfer. His research projects focus on bacteriophage-based biotechnology and include the use of coliphages to design and construct vectors for the development of novel vaccines, pharmaceuticals and gene delivery systems, and the identification and application of novel phage genomic anti-bacterial genes with potential phage therapy applications.
Roderick also comes to the UW with an MBA specialized in biotechnology management and commercialization, and is heavily involved in developing and delivering the School of Pharmacy's business curriculum.
Dr. Nancy Waite Associate Professor
Associate Director, Practice-Based Education
519-888-4485
nmwaite@uwaterloo.ca
Nancy was most recently an Associate Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto, where she was deeply involved in curricular planning. Prior to this, Nancy was Manager, Department of Pharmacy Practice at the Albany College of Pharmacy. She earned her professional degree from the University of Toronto, and completed her Pharm D and post-doctoral studies at Wayne State University in Detroit. As Associate Director, Practice-Based Education, Nancy is developing the vision, program objectives and long-range plan for practice-based education. She will guide initiatives relating to the co-op experiential program, professional lab courses and post-graduate residency/fellowship programs. Nancy also provides leadership in developing integrated learning opportunities with the satellite McMaster School of Medicine and the UW School of Optometry.
Dr. Shawn Wettig Assistant Professor, Pharmaceutical Sciences
519-888-4567 x21303
wettig@uwaterloo.ca
Dr. Wettig comes to UW after completing a post-doctoral fellowship at the College of Pharmacy and Nutrition at the University of Saskatchewan, where he was involved in Dr. Marianna Foldvari’s initiatives in bio-nanotechnology specifically relating to self-assembling delivery systems for gene therapy applications. His work has focused on the rational design, synthesis and characterization of novel surface-active compounds (surfactants) for use in non-viral gene therapy vectors. He obtained his Ph.D. studying the physical chemistry of novel mixed surfactant/polymer systems with Dr. Ron Verrall in the Department of Chemistry at the University of Saskatchewan. Dr. Wettig’s research at UW will focus on the design of novel self-assembling systems for drug delivery applications and physicochemical studies of the interactions of these systems with macromolecules such as proteins and DNA. For more details on his research program see Dr. Wettig’s research website.
Research Professor
Anson Tang
Anson Tang
Assistant Director, Experiential Learning
Clinical Lecturer
519-888-4567 x21304
Anson comes to UW with broad pharmacy career experience. He earned his B.Sc.Phm degree from the University of Toronto, and went on to complete a B.A. (French) degree at Glendon College, York University, and a MBA at the Schulich School of Business, York University (MBA Exchange: China Europe International Business School, in Shanghai). His career path has taken him through roles in community pharmacy, multinational firms within pharmaceutical industry, and the drug insurance sector of health business management. Anson’s current interests include experiential education in relation to professional competence, as well as drug payer themes in healthcare systems. As Assistant Director, Anson is spearheading the experiential component at the School of Pharmacy, both nationally and internationally, including co-op placements, community service learning initiatives, and clinical placements in the final year.
School of Pharmacy
10 Victoria St. S
Kitchener, Ontario, Canada N2G 1C5
Phone: (519) 888-4499
Fax: (519) 888-7910
Contact Us | School of Pharmacy | Faculty of Science